BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 2000
View Archived Issues
Active Biotech updates agreements for traveler's diarrhea vaccines
Read More
Insulin demonstrates antiatherosclerotic properties
Read More
Trial reveals utility of acupuncture in treating cocaine dependence
Read More
Vanadocenes induce germ cell apoptosis in mouse model of testicular cancer
Read More
Roche reports synthesis and antitumor activity of Ro-27-0574
Read More
Neurokinin antagonists under development for treatment of respiratory diseases
Read More
Sigma-1 and sigma-2 receptor ligands developed
Read More
Identification of dual Na+/Ca2+ blocker with antioxidant activity reported by Suntory
Read More
Synthetic analogues of 1alpha,25-(OH)2D3 may be useful in cancer chemoprevention
Read More
DuPont provides funding for large trial of cardiac imaging in diabetic patients
Read More
Phase I trial of novel anticancer treatment under way
Read More
Opioid receptor ligands under study at Pfizer
Read More
New compounds interacting with opioid receptors useful for IBS, etc.
Read More
AT1 antagonists in the treatment of CHF
Read More
CRF antagonists from DuPont reportedly useful in depression, etc.
Read More
Yeda presents new antiretroviral conjugates
Read More
New testosterone derivatives patented by Schering AG
Read More
FDA approves Advair Diskus for treatment of asthma
Read More
Spironolactone improves survival in CHF, possibly by limiting cardiac fibrosis
Read More
FDA accepts Celebrex sNDA for filing
Read More
Phase II trial to commence for diabetes vaccine
Read More
Individuals with manic depression may have lower heart attack risks
Read More
Inex broadens Onco TCS clinical trial program
Read More
Chymase inhibition -- a route to cardiovascular drug discovery
Read More
Taro to market and distribute Periostat in Israel
Read More